Robert A Bradway insider trades

Open-market stock purchases and sales by Robert A Bradway, Chairman, CEO and President at Amgen Inc, from SEC Form 4 filings since Mar 12, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +271%.

Recent trades

DateStockTradeValue
May 7, 2026AMGN Amgen IncSold (not open market)$688K
May 6, 2026AMGN Amgen IncSold (not open market)$561K
May 5, 2026AMGN Amgen IncBought (not open market)—
May 5, 2026AMGN Amgen IncBought (not open market)$26.1M
May 2, 2026AMGN Amgen IncSold (not open market)$868K
May 2, 2026AMGN Amgen IncSold (not open market)$800K
Apr 1, 2026BA Boeing CoBought (not open market)—
Mar 16, 2026AMGN Amgen IncSold (not open market)$7.8M
Mar 4, 2026AMGN Amgen IncSold (not open market)$32M
Mar 4, 2026AMGN Amgen IncBought (not open market)—
Mar 3, 2026AMGN Amgen IncBought (not open market)—
Jan 2, 2026BA Boeing CoBought (not open market)—

Companies traded

  • AMGN Amgen Inc: 1 buy, 2 sales, last May 7, 2026
  • BA Boeing Co: other filings, last Apr 1, 2026
  • NSC Norfolk Southern Corp: other filings, last Mar 10, 2017

Get free alerts when Robert A Bradway files a new trade →